Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study. (PHARMACOP)

Ghent University Hospital (UZ)

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Treatments: Behavioral: pharmaceutical care intervention

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01260389

EC/2010/587

Details and patient eligibility

About

This study would like to test the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in Chronic Obstructive Pulmonary Disease (COPD) patients over a 3 month-period.

Full description

Effective pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) not only involves prescription of recommended medicines by the physician, but also implies correct use of the prescribed medication by the patient (ie, good drug adherence and correct inhalation technique). Community pharmacists could help to improve the latter aspect, by delivering pharmaceutical care. The present randomised controlled trial will study the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in COPD patients over a 3 month-period.

Enrollment: 734 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• daily use of Chronic Obstructive Pulmonary Disease (COPD)-medication: (Global initiative for chronic Obstructive Lung Disease: GOLD stadia I-IV)
• 50 years of age or older
• smoking history of at least 10 pack-years

Exclusion criteria

• having asthma
• analphabetism

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

734 participants in 2 patient groups

control group

No Intervention group

Description:

Usual pharmacist care in patients with Chronic Obstructive Pulmonary Disease (COPD).

pharmaceutical care intervention

Experimental group

Description:

A pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD).

Treatment:

Behavioral: pharmaceutical care intervention